The Filing Desk

Afya

AFYA · Nasdaq · Consumer Discretionary · Financials, fiscal 2017 to 2025

AFYA · Last close · November 19, 2026
$9.72

Afya's revenue rose 11.9% to R$3.7 billion in fiscal 2025. Its operating margin was 32.8%, up from 30.6% a year earlier. Free cash flow was R$1.4 billion, up 5.4%. It paid out R$147 million in dividends and buybacks, 11% of free cash flow. The diluted share count rose 0.1%.

AFYA LIMITED Latest fiscal year ended December 31, 2025 20-F filed March 31, 2026 · 0001292814-26-002013 Updated
Revenue
R$3.7B
11.9%
Operating margin
32.8%
2.2 pts
Net income
R$752M
19.1%
Free cash flow
R$1.4B
5.4%
Return on capital
16.8%
1.7 pts

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

About these figures. Afya is a foreign company: it files an annual report on Form 20-F, prepared under international accounting standards (IFRS), instead of a 10-K, and no quarterly reports, so this page has fiscal years only. Its shares trade in the US as American depositary shares (ADSs), and one ADS can stand for several ordinary shares, so per-share figures are per ordinary share and the page has no market value, P/E or valuation model. Its figures are in BRL, as it reports them: they aren't converted to US dollars.

What Afya does

Afya is a medical education and technology company in Brazil. It runs medical schools and other health programs, and sells digital courses and software to students and doctors across the country. It says it has the largest medical education footprint in Brazil, based on the medical school seats approved by the education ministry (MEC).

It reports three segments. Undergraduate provides degree courses, mostly in medicine and other health sciences, at its campuses. Continuing Education sells residency preparation, specialization and graduate courses for physicians, delivered online and in person. Medical Practice Solutions sells clinical reference apps, practice management software, electronic prescriptions and financing tools for doctors. Most revenue comes from student tuition.

As of December 31, 2025, Afya had 86,025 enrolled students. It has grown partly by buying schools, including multi-discipline schools that also teach non-health subjects such as law and business, which it says are not part of its long-term plan.

Its biggest risks, as it describes them

  • Brazilian rules on opening medical courses and adding seats can change and are open to court challenge.
  • Hospitals and municipal schools may open medical programs under easier rules than Afya faces.
  • Falling behind on updating its content and products, including with new artificial intelligence tools.
  • Its dependence on tuition from medical programs, where more competition could cut growth and margins.
From Afya's annual report on Form 20-F, filed March 31, 2026, in our words; the 20-F has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
BRL billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
BRL billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

From fiscal 2017 to 2025, earnings per share grew 24.7% a year and net income 42.0% a year, as new shares raised the share count by 184% and diluted each share's earnings.

Diluted earnings per share
BRL per ordinary share, fiscal years; loss years in red. One US-listed ADS can stand for several ordinary shares.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
BRL billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
BRL billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments7491,0935539111,125
Debt incl. finance leases1,3751,8831,8012,1952,054
Net debt (negative means net cash)6267901,2481,284929
Net debt to EBITDA1.1x0.9x1.2x0.9x0.6x
Debt to equity0.5x0.6x0.5x0.5x0.4x
Interest coverage1.8x1.9x1.7x2.2x2.2x
Current ratio1.6x1.8x1.1x1.4x2.2x
Quick ratio1.6x1.8x1.1x1.4x2.2x
BRL millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
BRL billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
BRL billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
BRL billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score6 of 97 of 97 of 9
Rule of 4055.6%54.1%48.8%
Altman Z''2.372.853.68
Accruals ratio−8.9%−9.8%−8.6%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positivePassPassPass
Cash from operations is positivePassPassPass
Return on assets roseFailPassPass
Cash from operations exceeds net incomePassPassPass
Debt fell relative to assetsPassFailPass
Current ratio roseFailPassPass
Share count didn't risePassFailFail
Gross margin roseFailPassPass
Revenue rose relative to assetsPassPassFail
F-score6 of 97 of 97 of 9
Companies that report no gross profit are scored on the other eight.

Compare

Put Afya side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
AfyaFY2511.9%32.8%36.9%16.8%0.6x7
TAL Education GroupFY2633.7%9.2%16.9%———Compare
GrahamFY252.5%4.8%5.6%3.1%1.8x5Compare
StrideFY264.7%17.9%17.2%31.3%−0.7x6Compare
New Oriental Education & Technology GroupFY2615.5%11.4%13.8%19.4%−2.2x6Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

9 years of figures

Fiscal yearFY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue2163347511,2011,7192,3292,8763,3043,697
Revenue growth—54.6%124.8%60.0%43.1%35.5%23.5%14.9%11.9%
Gross profit921664427661,0671,4701,7662,0892,383
Research and development—————————
Operating income49962053634416647671,0121,213
Net income4586154292223374386632752
Diluted EPS (BRL)1.411.812.023.122.374.124.276.938.24
Diluted shares (millions)324876949491909191
Cash flow
Cash from operations40802993726318441,0441,4331,532
Capital expenditure17195790126168118137166
Free cash flow23622422825056769251,2961,366
Dividends paid26521319201918147
Share buybacks000000000
Acquisitions000000000
Stock-based compensation—218334331323215
Balance sheet at fiscal year end
Cash and short-term investments26629431,0457491,0935539111,125
Debt incl. finance leases—78606181,3751,8831,8012,1952,054
Total assets—9182,9124,7936,4477,2007,5848,8309,358
Total liabilities—3287991,9593,4473,9493,9424,5194,467
Shareholders' equity475022,0652,7822,9483,1993,6024,2704,852
Margins and ratios
Gross margin42.6%49.7%58.9%63.8%62.1%63.1%61.4%63.2%64.5%
Operating margin22.8%28.9%27.3%30.2%25.6%28.5%26.7%30.6%32.8%
Net margin21.0%25.9%20.5%24.3%13.0%16.0%13.4%19.1%20.4%
Free cash flow margin10.7%18.5%32.3%23.4%29.4%29.0%32.2%39.2%36.9%
Rule of 40 (growth + FCF margin)—73.1%157.1%83.5%72.5%64.5%55.6%54.1%48.8%
Return on capital——20.6%18.4%12.9%15.9%16.2%18.5%16.8%
Return on equity——12.0%12.1%7.8%12.2%11.4%16.1%16.5%
Return on assets——8.0%7.6%4.0%5.5%5.2%7.7%8.3%
Net debt to EBITDA—0.1x−3.2x−0.9x1.1x0.9x1.2x0.9x0.6x
BRL millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, BRL millions)
Source: Afya's Form 20-F filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Afya.